Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma

Neoplasia (United States)

Volumn 15, Issue 7, 2013, Pages 840-847

  Richichi, Cristina ^a   Brescia, Paola ^a   Alberizzi, Valeria ^a   Fornasari, Lorenzo ^a   Pelicci, Giuliana ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4, 5 DIMETHYL 2 THIAZOLYL) 2, 5 DIPHENYLTETRAZOLIUM BROMIDE; CD133 ANTIGEN; CD15 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCIDENCE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 84879667842     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.13662     Document Type: Article

References (31)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, and Kleihues P (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109.
2. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, and Peault B (1992). Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89, 2804-2808.
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, and Rich JN (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
4. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, and Wahl GM (2006). Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66, 9339-9344.
5. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, and Vescovi A (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64, 7011-7021.
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, and Clarke MF (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988.
8. Dick JE (2008). Stem cell concepts renew cancer research. Blood 112, 4793-4807.
9. Kelly K and Yin JJ (2008). Prostate cancer and metastasis initiating stem cells. Cell Res 18, 528-537.
10. Lee CJ, Dosch J, and Simeone DM (2008). Pancreatic cancer stem cells. J Clin Oncol 26, 2806-2812.
11. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, and Morrison SJ (2008). Efficient tumour formation by single human melanoma cells. Nature 456, 593-598.
12. Reya T, Morrison SJ, Clarke MF, and Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, and De Maria R (2007). Identification and expansion of human colon-cancer initiating cells. Nature 445, 111-115.
14. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, and Parada LF (2012). A restricted cell population propagates glioblastoma growth after chemo therapy. Nature 488, 522-526.
15. Deleyrolle LP, Harding A, Cato K, Siebzehnrubl FA, Rahman M, Azari H, Olson S, Gabrielli B, Osborne G, Vescovi A, et al. (2011). Evidence for label retaining tumour-initiating cells in human glioblastoma. Brain 134, 1331-1343.
16. Ortensi B, Osti D, Pellegatta S, Pisati F, Brescia P, Fornasari L, Levi D, Gaetani P, Colombo P, Ferri A, et al. (2012). Rai is a new regulator of neural progenitor migration and glioblastoma invasion. Stem Cells 30, 817-832.
17. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. (2006). Molecular subclasses of high grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173.
18. Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, and Pelicci G (2013). CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31, 857-869.
19. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403.
20. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, Depinho RA, et al. (2007). Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53, 503-517.
21. Yuan H, Corbi N, Basilico C, and Dailey L (1995). Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9, 2635-2645.
22. Lanzkron SM, Collector MI, and Sharkis SJ (1999). Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. Blood 93, 1916-1921.
23. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, and Di Fiore PP (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62-73.
24. Ono Y, Masuda S, Nam HS, Benezra R, Miyagoe-Suzuki Y, and Takeda S (2012). Slow-dividing satellite cells retain long-term self-renewal ability in adult muscle. J Cell Sci 125, 1309-1317.
25. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, and Pelicci PG (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095.
26. Dembinski JL and Krauss S (2009). Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 26, 611-623.
27. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, and Herlyn M (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594.
28. Rietze RL and Reynolds BA (2006). Neural stem cell isolation and characterization. Methods Enzymol 419, 3-23.
29. Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, Murrell W, and Langmoen IA (2010). Brain tumor stem cells maintain over all phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro Oncol 12, 1220-1230.
30. Driessens G, Beck B, Caauwe A, Simons BD, and Blanpain C (2012). Defining the mode of tumour growth by clonal analysis. Nature 488, 527-530.
31. Louis SA, Rietze RL, Deleyrolle L, Wagey RE, Thomas TE, Eaves AC, and Reynolds BA (2008). Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells 26, 988-996.